1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

ARIAD

Anonymous board for ARIAD


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    4
    Views:
    3,893
  2. Anonymous
    Replies:
    37
    Views:
    14,996
  3. anonymous
    Replies:
    5
    Views:
    2,897
  4. anonymous
    Replies:
    5
    Views:
    4,403
  5. anonymous
    Replies:
    7
    Views:
    3,871
  6. Anonymous
    Replies:
    7
    Views:
    8,293
  7. Anonymous
    Replies:
    3
    Views:
    4,422
  8. Anonymous
    Replies:
    1
    Views:
    3,747
  9. Anonymous
    Replies:
    7
    Views:
    5,696
  10. Anonymous
    Replies:
    39
    Views:
    15,954
  11. Anonymous
    Replies:
    0
    Views:
    3,138
  12. Anonymous
    Replies:
    0
    Views:
    2,524
  13. Anonymous
    Replies:
    5
    Views:
    5,949
  14. Anonymous
    Replies:
    2
    Views:
    3,628
  15. Anonymous
    Replies:
    13
    Views:
    5,244
  16. Anonymous
    Replies:
    51
    Views:
    14,555
  17. Anonymous
    Replies:
    18
    Views:
    6,051
  18. Anonymous
    Replies:
    13
    Views:
    6,385
  19. Anonymous
    Replies:
    6
    Views:
    3,354
  20. Anonymous
    Replies:
    55
    Views:
    19,312

Thread Display Options

Loading...